Other

Loss Contingency Estimate Of Possible Loss

ResMed Loss Contingency Estimate Of Possible Loss increased by 23.8% to $33.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.8%, from $35.50M to $33.80M. Over 3 years (FY 2022 to FY 2025), Loss Contingency Estimate Of Possible Loss shows an upward trend with a 12.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2026
Last reportedQ1 2026

How to read this metric

An increase suggests rising legal or regulatory risk, while a decrease indicates a reduction in potential exposure.

Detailed definition

This represents the estimated potential financial exposure from legal proceedings, claims, or other contingencies that a...

Peer comparison

Peers in the financial services sector disclose these estimates based on legal assessment, often varying significantly based on current litigation cycles.

Metric ID: other_loss_contingency_estimate_of_possible_loss

Historical Data

16 periods
 Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$24.20M$22.40M$24.10M$29.70M$32.60M$28.90M$29.20M$35.00M$35.80M$26.40M$28.50M$35.50M$34.10M$25.50M$27.30M$33.80M
QoQ Change-7.4%+7.6%+23.2%+9.8%-11.3%+1.0%+19.9%+2.3%-26.3%+8.0%+24.6%-3.9%-25.2%+7.1%+23.8%
YoY Change+34.7%+29.0%+21.2%+17.8%+9.8%-8.7%-2.4%+1.4%-4.7%-3.4%-4.2%-4.8%
Range$22.40M$35.80M
CAGR+9.3%
Avg YoY Growth+7.1%
Median YoY Growth-0.5%
Current Streak2 quarters growth

Frequently Asked Questions

What is ResMed's loss contingency estimate of possible loss?
ResMed (RMD) reported loss contingency estimate of possible loss of $33.80M in Q1 2026.
How has ResMed's loss contingency estimate of possible loss changed year-over-year?
ResMed's loss contingency estimate of possible loss decreased by 4.8% year-over-year, from $35.50M to $33.80M.
What is the long-term trend for ResMed's loss contingency estimate of possible loss?
Over 3 years (2022 to 2025), ResMed's loss contingency estimate of possible loss has grown at a 12.1% compound annual growth rate (CAGR), from $24.20M to $34.10M.
What does loss contingency estimate of possible loss mean?
The estimated maximum potential financial loss from ongoing legal or regulatory matters that are not yet certain.